Celavie Biosciences CEO Sandy Solomon sat down with Proactive’s Christine Corrado at the BIO CEO & Investor Conference in New York. The California-based company is developing regenerative stem cell therapies to treat Parkinson’s disease and other central nervous system disorders.

viewCelavie Biosciences
Celavie Biosciences advancing its five year exploratory study in Parkinson's Disease
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Industry & services
New space ETF on the horizon lifts shares in Virgin Galactic, Maxar and SRAC
2 days, 6 hours ago
Health
Tiziana Life Sciences hires scientist with track record of successfully...
3 days, 13 hours ago
Retail & consumer
NexTech AR touts record C$7.3M 4Q bookings, projects triple its 2020...
4 days, 6 hours ago
Finance
Argo Blockchain to begin trading on OTCQB venture market from Wednesday
3 days, 12 hours ago